These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28446312)

  • 21. Gilbert syndrome: the UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism.
    Gil J; Sąsiadek MM
    Biomark Med; 2012 Apr; 6(2):223-30. PubMed ID: 22448797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
    Lee JS; Wang J; Martin M; Germer S; Kenwright A; Benayed R; Spleiss O; Platt A; Pilson R; Hemmings A; Weinblatt ME; Kaplowitz N; Krasnow J
    Pharmacogenet Genomics; 2011 Jul; 21(7):365-74. PubMed ID: 21412181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequencies of A(TA)7TAA, G71R, and G493R mutations of the UGT1A1 gene in the Malaysian population.
    Yusoff S; Van Rostenberghe H; Yusoff NM; Talib NA; Ramli N; Ismail NZ; Ismail WP; Matsuo M; Nishio H
    Biol Neonate; 2006; 89(3):171-6. PubMed ID: 16210851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].
    Ouyang Y; Qiao C; Wang J; Xiao L; Zhang S
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1369-73. PubMed ID: 26178351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of diagnostic value of UGT1A1 gene detection in Gilbert syndrome].
    Zhang M; Li WN; Chen G; Xu X; Qi JY
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):143-149. PubMed ID: 33685083
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.
    Hsieh TY; Shiu TY; Huang SM; Lin HH; Lee TC; Chen PJ; Chu HC; Chang WK; Jeng KS; Lai MM; Chao YC
    Pharmacogenet Genomics; 2007 Apr; 17(4):229-36. PubMed ID: 17496722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage between A(TA)7TAA and -3279T>G mutations in UGT1A1 is not essential for pathogenesis of Gilbert syndrome.
    Jirsa M; Petrasek J; Vitek L
    Liver Int; 2006 Dec; 26(10):1302-3. PubMed ID: 17105600
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular diagnostics of myeloproliferative neoplasms.
    Langabeer SE; Andrikovics H; Asp J; Bellosillo B; Carillo S; Haslam K; Kjaer L; Lippert E; Mansier O; Oppliger Leibundgut E; Percy MJ; Porret N; Palmqvist L; Schwarz J; McMullin MF; Schnittger S; Pallisgaard N; Hermouet S;
    Eur J Haematol; 2015 Oct; 95(4):270-9. PubMed ID: 25951317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of mutations in JAK2 exons 12-15 by Sanger sequencing.
    Alghasham N; Alnouri Y; Abalkhail H; Khalil S
    Int J Lab Hematol; 2016 Feb; 38(1):34-41. PubMed ID: 26361084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance].
    Tang Q; Zhang XW; Xia L; Jiang NK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):151-156. PubMed ID: 28245393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
    Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS
    Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexistence of Gilbert syndrome with hereditary haemolytic anaemias.
    Rawa K; Adamowicz-Salach A; Matysiak M; Trzemecka A; Burzynska B
    J Clin Pathol; 2012 Jul; 65(7):663-5. PubMed ID: 22554963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of the UGT1A1*28 Polymorphism in a Romanian Cohort of Gilbert Syndrome Individuals.
    Radoi VE; Ursu RI; Poenaru E; Arsene C; Bohiltea CL; Bohiltea R
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):25-28. PubMed ID: 28338110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome.
    Sutomo R; Laosombat V; Sadewa AH; Yokoyama N; Nakamura H; Matsuo M; Nishio H
    Pediatr Int; 2002 Aug; 44(4):427-32. PubMed ID: 12139570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis.
    del Giudice EM; Perrotta S; Nobili B; Specchia C; d'Urzo G; Iolascon A
    Blood; 1999 Oct; 94(7):2259-62. PubMed ID: 10498597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.
    Akaba K; Kimura T; Sasaki A; Tanabe S; Wakabayashi T; Hiroi M; Yasumura S; Maki K; Aikawa S; Hayasaka K
    J Hum Genet; 1999; 44(1):22-5. PubMed ID: 9929972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of chronic myeloproliferative neoplasias in México.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Ortiz-López R; Rivas-Llamas R; Gómez-Almaguer D; Ruiz-Delgado GJ
    Hematology; 2009 Oct; 14(5):261-5. PubMed ID: 19843380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
    Trifa AP; Bănescu C; Tevet M; Bojan A; Dima D; Urian L; Török-Vistai T; Popov VM; Zdrenghea M; Petrov L; Vasilache A; Murat M; Georgescu D; Popescu M; Pătrinoiu O; Balea M; Costache R; Coleș E; Șaguna C; Berbec N; Vlădăreanu AM; Mihăilă RG; Bumbea H; Cucuianu A; Popp RA
    Br J Haematol; 2016 Jul; 174(2):218-26. PubMed ID: 27061303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.
    Medinger M; Skoda R; Gratwohl A; Theocharides A; Buser A; Heim D; Dirnhofer S; Tichelli A; Tzankov A
    Br J Haematol; 2009 Jul; 146(2):150-7. PubMed ID: 19466975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.